

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 6.16416672 |
| 2 | ATP synthesis coupled proton transport (GO:0015986) | 5.90228435 |
| 3 | energy coupled proton transport, down electrochemical gradient (GO:0015985) | 5.90228435 |
| 4 | skeletal muscle contraction (GO:0003009) | 5.86638871 |
| 5 | cardiac myofibril assembly (GO:0055003) | 5.47611305 |
| 6 | sarcomere organization (GO:0045214) | 5.42417217 |
| 7 | mitochondrial electron transport, NADH to ubiquinone (GO:0006120) | 5.37353502 |
| 8 | positive regulation of ryanodine-sensitive calcium-release channel activity (GO:0060316) | 5.10489324 |
| 9 | creatine metabolic process (GO:0006600) | 5.02429303 |
| 10 | respiratory electron transport chain (GO:0022904) | 5.00018270 |
| 11 | regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO | 4.97466570 |
| 12 | regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880) | 4.93769572 |
| 13 | tricarboxylic acid cycle (GO:0006099) | 4.92747867 |
| 14 | negative regulation of potassium ion transmembrane transporter activity (GO:1901017) | 4.88850709 |
| 15 | electron transport chain (GO:0022900) | 4.87421706 |
| 16 | actin-myosin filament sliding (GO:0033275) | 4.83525803 |
| 17 | muscle filament sliding (GO:0030049) | 4.83525803 |
| 18 | myofibril assembly (GO:0030239) | 4.80382022 |
| 19 | regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882) | 4.71465919 |
| 20 | cardiac muscle contraction (GO:0060048) | 4.65647912 |
| 21 | negative regulation of potassium ion transmembrane transport (GO:1901380) | 4.50735726 |
| 22 | response to inactivity (GO:0014854) | 4.48482275 |
| 23 | regulation of cell communication by electrical coupling (GO:0010649) | 4.40517374 |
| 24 | muscle contraction (GO:0006936) | 4.36075001 |
| 25 | regulation of ryanodine-sensitive calcium-release channel activity (GO:0060314) | 4.31219575 |
| 26 | regulation of relaxation of muscle (GO:1901077) | 4.27141075 |
| 27 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 4.10596287 |
| 28 | regulation of acyl-CoA biosynthetic process (GO:0050812) | 4.08378087 |
| 29 | response to muscle activity (GO:0014850) | 4.07830515 |
| 30 | regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307) | 4.02526436 |
| 31 | sarcoplasmic reticulum calcium ion transport (GO:0070296) | 4.01512495 |
| 32 | actin-mediated cell contraction (GO:0070252) | 4.01328165 |
| 33 | regulation of acetyl-CoA biosynthetic process from pyruvate (GO:0010510) | 3.97715311 |
| 34 | regulation of membrane repolarization (GO:0060306) | 3.96766930 |
| 35 | regulation of actin filament-based movement (GO:1903115) | 3.94571176 |
| 36 | muscle system process (GO:0003012) | 3.93392741 |
| 37 | plasma membrane repair (GO:0001778) | 3.92795882 |
| 38 | cardiac muscle hypertrophy in response to stress (GO:0014898) | 3.89458119 |
| 39 | muscle hypertrophy in response to stress (GO:0003299) | 3.89458119 |
| 40 | cardiac muscle adaptation (GO:0014887) | 3.89458119 |
| 41 | regulation of cofactor metabolic process (GO:0051193) | 3.88606736 |
| 42 | regulation of coenzyme metabolic process (GO:0051196) | 3.88606736 |
| 43 | striated muscle contraction (GO:0006941) | 3.78209476 |
| 44 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 3.75813813 |
| 45 | cardiac muscle cell development (GO:0055013) | 3.75527101 |
| 46 | cell communication by electrical coupling (GO:0010644) | 3.72269254 |
| 47 | oxidative phosphorylation (GO:0006119) | 3.66565445 |
| 48 | cardiac muscle tissue morphogenesis (GO:0055008) | 3.65007896 |
| 49 | muscle fiber development (GO:0048747) | 3.59769689 |
| 50 | regulation of ATPase activity (GO:0043462) | 3.56693814 |
| 51 | regulation of ATP catabolic process (GO:1903289) | 3.56693814 |
| 52 | ATP biosynthetic process (GO:0006754) | 3.56561075 |
| 53 | ventricular cardiac muscle cell action potential (GO:0086005) | 3.56387279 |
| 54 | actomyosin structure organization (GO:0031032) | 3.56382307 |
| 55 | regulation of sarcomere organization (GO:0060297) | 3.55647884 |
| 56 | cardiac muscle hypertrophy (GO:0003300) | 3.53532907 |
| 57 | positive regulation of potassium ion transmembrane transporter activity (GO:1901018) | 3.52961578 |
| 58 | striated muscle adaptation (GO:0014888) | 3.51105043 |
| 59 | cell communication involved in cardiac conduction (GO:0086065) | 3.50525000 |
| 60 | regulation of striated muscle contraction (GO:0006942) | 3.49977662 |
| 61 | cardiac cell development (GO:0055006) | 3.46957659 |
| 62 | detection of calcium ion (GO:0005513) | 3.45171739 |
| 63 | ventricular cardiac muscle tissue morphogenesis (GO:0055010) | 3.44624753 |
| 64 | adult heart development (GO:0007512) | 3.43557386 |
| 65 | NADH metabolic process (GO:0006734) | 3.42047867 |
| 66 | heart contraction (GO:0060047) | 3.41930941 |
| 67 | heart process (GO:0003015) | 3.41930941 |
| 68 | regulation of skeletal muscle contraction (GO:0014819) | 3.41432039 |
| 69 | regulation of atrial cardiac muscle cell membrane depolarization (GO:0060371) | 3.41229703 |
| 70 | striated muscle hypertrophy (GO:0014897) | 3.37852511 |
| 71 | regulation of the force of heart contraction (GO:0002026) | 3.37719307 |
| 72 | skeletal muscle fiber development (GO:0048741) | 3.37351222 |
| 73 | positive regulation of potassium ion transmembrane transport (GO:1901381) | 3.34910035 |
| 74 | striated muscle cell development (GO:0055002) | 3.33923000 |
| 75 | muscle tissue morphogenesis (GO:0060415) | 3.30565357 |
| 76 | relaxation of cardiac muscle (GO:0055119) | 3.30447622 |
| 77 | carnitine shuttle (GO:0006853) | 3.29370887 |
| 78 | synaptic vesicle exocytosis (GO:0016079) | 3.22902873 |
| 79 | regulation of calcium ion transmembrane transporter activity (GO:1901019) | 3.22570099 |
| 80 | regulation of calcium ion transmembrane transport (GO:1903169) | 3.22570099 |
| 81 | myotube cell development (GO:0014904) | 3.21195809 |
| 82 | negative regulation of protein localization to cell surface (GO:2000009) | 3.19602925 |
| 83 | muscle cell cellular homeostasis (GO:0046716) | 3.18574043 |
| 84 | regulation of calcineurin-NFAT signaling cascade (GO:0070884) | 3.17723496 |
| 85 | positive regulation of cation channel activity (GO:2001259) | 3.17324874 |
| 86 | 2-oxoglutarate metabolic process (GO:0006103) | 3.17262676 |
| 87 | positive regulation of calcium ion transmembrane transporter activity (GO:1901021) | 3.14153112 |
| 88 | heart trabecula formation (GO:0060347) | 3.12093120 |
| 89 | relaxation of muscle (GO:0090075) | 3.10486575 |
| 90 | cardiac muscle cell action potential involved in contraction (GO:0086002) | 3.09062007 |
| 91 | regulation of cardiac muscle contraction (GO:0055117) | 3.08939339 |
| 92 | glycogen catabolic process (GO:0005980) | 3.08623428 |
| 93 | positive regulation of sodium ion transport (GO:0010765) | 3.08581104 |
| 94 | regulation of potassium ion transmembrane transporter activity (GO:1901016) | 3.08006250 |
| 95 | cardiac muscle cell action potential (GO:0086001) | 3.07899971 |
| 96 | negative regulation of calcium ion transmembrane transport (GO:1903170) | 3.07812883 |
| 97 | negative regulation of calcium ion transmembrane transporter activity (GO:1901020) | 3.07812883 |
| 98 | vocalization behavior (GO:0071625) | 3.07163090 |
| 99 | gluconeogenesis (GO:0006094) | 3.06822671 |
| 100 | negative regulation of cardiac muscle cell apoptotic process (GO:0010667) | 3.06485383 |
| 101 | regulation of heart rate (GO:0002027) | 3.06389515 |
| 102 | glucan biosynthetic process (GO:0009250) | 3.05566523 |
| 103 | glycogen biosynthetic process (GO:0005978) | 3.05566523 |
| 104 | negative regulation of ryanodine-sensitive calcium-release channel activity (GO:0060315) | 3.05236258 |
| 105 | regulation of heart rate by cardiac conduction (GO:0086091) | 3.04774443 |
| 106 | skeletal muscle adaptation (GO:0043501) | 3.04362519 |
| 107 | cardiac conduction (GO:0061337) | 3.03939397 |
| 108 | ATP hydrolysis coupled proton transport (GO:0015991) | 3.02546111 |
| 109 | energy coupled proton transmembrane transport, against electrochemical gradient (GO:0015988) | 3.02546111 |
| 110 | regulation of cation channel activity (GO:2001257) | 3.02229360 |
| 111 | regulation of potassium ion transmembrane transport (GO:1901379) | 3.02022845 |
| 112 | cardiac chamber formation (GO:0003207) | 3.01043258 |
| 113 | hydrogen ion transmembrane transport (GO:1902600) | 2.99819950 |
| 114 | cardiac ventricle formation (GO:0003211) | 2.98667444 |
| 115 | purine ribonucleoside triphosphate biosynthetic process (GO:0009206) | 2.96614953 |
| 116 | negative regulation of potassium ion transport (GO:0043267) | 2.94758203 |
| 117 | regulation of muscle contraction (GO:0006937) | 2.93305002 |
| 118 | succinate metabolic process (GO:0006105) | 2.92568275 |
| 119 | membrane repolarization during cardiac muscle cell action potential (GO:0086013) | 2.92442096 |
| 120 | negative regulation of cytosolic calcium ion concentration (GO:0051481) | 2.90997607 |
| 121 | regulation of muscle system process (GO:0090257) | 2.90507934 |
| 122 | muscle hypertrophy (GO:0014896) | 2.90131621 |
| 123 | aspartate family amino acid catabolic process (GO:0009068) | 2.89888508 |
| 124 | neuron cell-cell adhesion (GO:0007158) | 2.89632526 |
| 125 | purine nucleoside triphosphate biosynthetic process (GO:0009145) | 2.89397856 |
| 126 | regulation of cardiac muscle cell contraction (GO:0086004) | 2.89082994 |
| 127 | regulation of sulfur metabolic process (GO:0042762) | 2.86577108 |
| 128 | actin filament-based movement (GO:0030048) | 2.84577737 |
| 129 | calcium-mediated signaling using intracellular calcium source (GO:0035584) | 2.82053124 |
| 130 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 2.82014150 |
| 131 | response to stimulus involved in regulation of muscle adaptation (GO:0014874) | 2.81684913 |
| 132 | neuronal action potential propagation (GO:0019227) | 2.81299443 |
| 133 | regulation of heart contraction (GO:0008016) | 2.78139304 |
| 134 | neurological system process involved in regulation of systemic arterial blood pressure (GO:0001976) | 2.77779361 |
| 135 | positive regulation of potassium ion transport (GO:0043268) | 2.77510290 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EZH2_22144423_ChIP-Seq_EOC_Human | 5.44727672 |
| 2 | GBX2_23144817_ChIP-Seq_PC3_Human | 3.32647270 |
| 3 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 3.27493227 |
| 4 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 2.99696014 |
| 5 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 2.95823278 |
| 6 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 2.76152885 |
| 7 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 2.62043810 |
| 8 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 2.60326066 |
| 9 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 2.53549760 |
| 10 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 2.52068945 |
| 11 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 2.52068945 |
| 12 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 2.37787537 |
| 13 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 2.34878986 |
| 14 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 2.27787683 |
| 15 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 2.24357075 |
| 16 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 2.22539087 |
| 17 | * MTF2_20144788_ChIP-Seq_MESCs_Mouse | 2.21856715 |
| 18 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 2.06050024 |
| 19 | TAF15_26573619_Chip-Seq_HEK293_Human | 2.03079971 |
| 20 | * EZH2_27294783_Chip-Seq_ESCs_Mouse | 2.00661322 |
| 21 | REST_21632747_ChIP-Seq_MESCs_Mouse | 1.95514083 |
| 22 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.95201542 |
| 23 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.85224506 |
| 24 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 1.83366365 |
| 25 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.81316671 |
| 26 | * SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.79883262 |
| 27 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 1.78370764 |
| 28 | VDR_22108803_ChIP-Seq_LS180_Human | 1.77167921 |
| 29 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.73985118 |
| 30 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 1.66829614 |
| 31 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.64617362 |
| 32 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.63696043 |
| 33 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.63212374 |
| 34 | * SMAD4_21799915_ChIP-Seq_A2780_Human | 1.60210931 |
| 35 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.59568608 |
| 36 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.59518337 |
| 37 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.50335414 |
| 38 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.48051621 |
| 39 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.47853508 |
| 40 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.47707033 |
| 41 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.47299717 |
| 42 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.45155881 |
| 43 | * SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.43807217 |
| 44 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.42008995 |
| 45 | * CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.41679079 |
| 46 | * GATA4_21415370_ChIP-Seq_HL-1_Mouse | 1.40650196 |
| 47 | P300_19829295_ChIP-Seq_ESCs_Human | 1.39299489 |
| 48 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 1.37374127 |
| 49 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.35496375 |
| 50 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.35170439 |
| 51 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.33893114 |
| 52 | FUS_26573619_Chip-Seq_HEK293_Human | 1.33355037 |
| 53 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.32795816 |
| 54 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.32119165 |
| 55 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.31815159 |
| 56 | MEF2A_21415370_ChIP-Seq_HL-1_Mouse | 1.31696679 |
| 57 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.28986934 |
| 58 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.28470499 |
| 59 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.28222003 |
| 60 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.27927331 |
| 61 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.21244492 |
| 62 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.19907343 |
| 63 | RCOR2_21632747_ChIP-Seq_MESCs_Mouse | 1.16912901 |
| 64 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.15209428 |
| 65 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 1.14225115 |
| 66 | CTCF_27219007_Chip-Seq_Bcells_Human | 1.14110232 |
| 67 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.12120310 |
| 68 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.11591615 |
| 69 | FOXP2_21765815_ChIP-ChIP_NEURO2A_Mouse | 1.10403539 |
| 70 | AR_25329375_ChIP-Seq_VCAP_Human | 1.09081622 |
| 71 | * RING1B_27294783_Chip-Seq_ESCs_Mouse | 1.09064211 |
| 72 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.07493476 |
| 73 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 1.04343396 |
| 74 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 1.04343396 |
| 75 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 1.01919094 |
| 76 | NKX2-5_21415370_ChIP-Seq_HL-1_Mouse | 1.01695817 |
| 77 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.01039098 |
| 78 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.00259876 |
| 79 | CRX_20693478_ChIP-Seq_ADULT_RETINA_Mouse | 0.99753141 |
| 80 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 0.98396249 |
| 81 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 0.96675147 |
| 82 | AR_19668381_ChIP-Seq_PC3_Human | 0.95905572 |
| 83 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 0.95185819 |
| 84 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.94748494 |
| 85 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 0.94400323 |
| 86 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 0.94185643 |
| 87 | JUN_21703547_ChIP-Seq_K562_Human | 0.94165377 |
| 88 | TRIM28_17542650_ChIP-ChIP_NTERA2_Human | 0.93041537 |
| 89 | ZNF263_19887448_ChIP-Seq_K562_Human | 0.92628357 |
| 90 | IGF1R_20145208_ChIP-Seq_DFB_Human | 0.92621861 |
| 91 | * EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 0.92462614 |
| 92 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 0.92297667 |
| 93 | * MYC_20876797_ChIP-ChIP_MEDULLOBLASTOMA_Human | 0.91285893 |
| 94 | STAT3_23295773_ChIP-Seq_U87_Human | 0.90662849 |
| 95 | TCF4_23295773_ChIP-Seq_U87_Human | 0.90518969 |
| 96 | CEBPB_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.90447314 |
| 97 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.90270938 |
| 98 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 0.89909918 |
| 99 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 0.89705849 |
| 100 | SOX9_26525672_Chip-Seq_HEART_Mouse | 0.88228694 |
| 101 | RNF2_27304074_Chip-Seq_NSC_Mouse | 0.87530969 |
| 102 | YAP1_20516196_ChIP-Seq_MESCs_Mouse | 0.87247894 |
| 103 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 0.85998156 |
| 104 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 0.85963612 |
| 105 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.85807818 |
| 106 | RCOR3_21632747_ChIP-Seq_MESCs_Mouse | 0.85591946 |
| 107 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 0.85467248 |
| 108 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 0.85074134 |
| 109 | TP53_20018659_ChIP-ChIP_R1E_Mouse | 0.84414927 |
| 110 | * BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 0.84347984 |
| 111 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 0.84007914 |
| 112 | RCOR1_19997604_ChIP-ChIP_NEURONS_Mouse | 0.83483114 |
| 113 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 0.83409937 |
| 114 | * MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 0.83346989 |
| 115 | RUNX2_22187159_ChIP-Seq_PCA_Human | 0.83167603 |
| 116 | * ZFP281_18757296_ChIP-ChIP_E14_Mouse | 0.82959079 |
| 117 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.82914830 |
| 118 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 0.82913209 |
| 119 | AHR_22903824_ChIP-Seq_MCF-7_Human | 0.82867102 |
| 120 | LMO2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.82262812 |
| 121 | ISL1_27105846_Chip-Seq_CPCs_Mouse | 0.81020338 |
| 122 | KLF5_20875108_ChIP-Seq_MESCs_Mouse | 0.79981909 |
| 123 | TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 0.79924663 |
| 124 | TET1_21490601_ChIP-Seq_MESCs_Mouse | 0.79220702 |
| 125 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 0.78990220 |
| 126 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 0.78588735 |
| 127 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 0.78421611 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002837_dystrophic_cardiac_calcinosis | 5.10874208 |
| 2 | MP0004084_abnormal_cardiac_muscle | 4.11027131 |
| 3 | MP0003646_muscle_fatigue | 3.93219623 |
| 4 | MP0004215_abnormal_myocardial_fiber | 3.57560784 |
| 5 | * MP0000751_myopathy | 3.56391656 |
| 6 | MP0004036_abnormal_muscle_relaxation | 3.37779987 |
| 7 | MP0000749_muscle_degeneration | 3.22350231 |
| 8 | MP0003880_abnormal_central_pattern | 2.99102644 |
| 9 | MP0004859_abnormal_synaptic_plasticity | 2.66833574 |
| 10 | MP0005330_cardiomyopathy | 2.63299601 |
| 11 | MP0004145_abnormal_muscle_electrophysio | 2.59269994 |
| 12 | MP0002972_abnormal_cardiac_muscle | 2.44562378 |
| 13 | MP0003137_abnormal_impulse_conducting | 2.35286647 |
| 14 | MP0005620_abnormal_muscle_contractility | 2.24827794 |
| 15 | MP0004484_altered_response_of | 2.18646087 |
| 16 | MP0003635_abnormal_synaptic_transmissio | 2.11281572 |
| 17 | MP0004087_abnormal_muscle_fiber | 2.10288237 |
| 18 | MP0004270_analgesia | 1.97313719 |
| 19 | MP0008775_abnormal_heart_ventricle | 1.95483370 |
| 20 | MP0004085_abnormal_heartbeat | 1.95121942 |
| 21 | MP0004233_abnormal_muscle_weight | 1.90397991 |
| 22 | MP0003122_maternal_imprinting | 1.86267794 |
| 23 | MP0009046_muscle_twitch | 1.84062192 |
| 24 | * MP0002106_abnormal_muscle_physiology | 1.82907058 |
| 25 | MP0009745_abnormal_behavioral_response | 1.82840862 |
| 26 | MP0006138_congestive_heart_failure | 1.79293719 |
| 27 | MP0001968_abnormal_touch/_nociception | 1.75334006 |
| 28 | MP0002064_seizures | 1.74147325 |
| 29 | MP0001544_abnormal_cardiovascular_syste | 1.72866030 |
| 30 | MP0005385_cardiovascular_system_phenoty | 1.72866030 |
| 31 | MP0000747_muscle_weakness | 1.70581121 |
| 32 | MP0000750_abnormal_muscle_regeneration | 1.68736731 |
| 33 | MP0002063_abnormal_learning/memory/cond | 1.66362265 |
| 34 | MP0002269_muscular_atrophy | 1.65578432 |
| 35 | MP0006276_abnormal_autonomic_nervous | 1.64859461 |
| 36 | MP0001529_abnormal_vocalization | 1.64387300 |
| 37 | MP0002736_abnormal_nociception_after | 1.59176613 |
| 38 | MP0002272_abnormal_nervous_system | 1.59150893 |
| 39 | MP0000759_abnormal_skeletal_muscle | 1.59093270 |
| 40 | MP0002735_abnormal_chemical_nociception | 1.58988952 |
| 41 | * MP0005369_muscle_phenotype | 1.56697461 |
| 42 | MP0002734_abnormal_mechanical_nocicepti | 1.53554990 |
| 43 | MP0005670_abnormal_white_adipose | 1.50311036 |
| 44 | MP0004130_abnormal_muscle_cell | 1.48431921 |
| 45 | MP0005451_abnormal_body_composition | 1.47823321 |
| 46 | MP0001440_abnormal_grooming_behavior | 1.46602434 |
| 47 | MP0002572_abnormal_emotion/affect_behav | 1.46498906 |
| 48 | MP0003221_abnormal_cardiomyocyte_apopto | 1.42488567 |
| 49 | MP0010630_abnormal_cardiac_muscle | 1.41753889 |
| 50 | MP0004924_abnormal_behavior | 1.35088338 |
| 51 | MP0005386_behavior/neurological_phenoty | 1.35088338 |
| 52 | MP0002822_catalepsy | 1.31245168 |
| 53 | MP0002067_abnormal_sensory_capabilities | 1.29352017 |
| 54 | MP0002127_abnormal_cardiovascular_syste | 1.29181237 |
| 55 | MP0001486_abnormal_startle_reflex | 1.27390315 |
| 56 | * MP0006036_abnormal_mitochondrial_physio | 1.22856081 |
| 57 | MP0000013_abnormal_adipose_tissue | 1.21479728 |
| 58 | MP0006035_abnormal_mitochondrial_morpho | 1.19932913 |
| 59 | MP0001970_abnormal_pain_threshold | 1.16999669 |
| 60 | MP0002184_abnormal_innervation | 1.14631572 |
| 61 | MP0002733_abnormal_thermal_nociception | 1.12505168 |
| 62 | MP0002909_abnormal_adrenal_gland | 1.11742973 |
| 63 | MP0003950_abnormal_plasma_membrane | 1.11052247 |
| 64 | MP0004510_myositis | 1.10896011 |
| 65 | MP0005623_abnormal_meninges_morphology | 1.09094390 |
| 66 | MP0005423_abnormal_somatic_nervous | 1.07428497 |
| 67 | MP0001905_abnormal_dopamine_level | 1.06867921 |
| 68 | MP0000778_abnormal_nervous_system | 1.05583304 |
| 69 | MP0000733_abnormal_muscle_development | 1.05168967 |
| 70 | MP0004142_abnormal_muscle_tone | 1.03195943 |
| 71 | MP0008569_lethality_at_weaning | 0.99966528 |
| 72 | MP0003828_pulmonary_edema | 0.99225840 |
| 73 | MP0001501_abnormal_sleep_pattern | 0.94771142 |
| 74 | MP0003329_amyloid_beta_deposits | 0.94081350 |
| 75 | MP0004858_abnormal_nervous_system | 0.90750362 |
| 76 | MP0002234_abnormal_pharynx_morphology | 0.88703665 |
| 77 | MP0009780_abnormal_chondrocyte_physiolo | 0.87455298 |
| 78 | * MP0005266_abnormal_metabolism | 0.87262084 |
| 79 | MP0002066_abnormal_motor_capabilities/c | 0.87252957 |
| 80 | MP0001984_abnormal_olfaction | 0.85199584 |
| 81 | MP0002557_abnormal_social/conspecific_i | 0.83414575 |
| 82 | MP0002882_abnormal_neuron_morphology | 0.81910568 |
| 83 | * MP0002332_abnormal_exercise_endurance | 0.81843567 |
| 84 | MP0002108_abnormal_muscle_morphology | 0.81239149 |
| 85 | MP0004811_abnormal_neuron_physiology | 0.79582518 |
| 86 | MP0000955_abnormal_spinal_cord | 0.77638614 |
| 87 | MP0004043_abnormal_pH_regulation | 0.74856066 |
| 88 | MP0005187_abnormal_penis_morphology | 0.74423790 |
| 89 | MP0001661_extended_life_span | 0.74169398 |
| 90 | MP0000230_abnormal_systemic_arterial | 0.73480605 |
| 91 | MP0002638_abnormal_pupillary_reflex | 0.72416937 |
| 92 | MP0000003_abnormal_adipose_tissue | 0.72227151 |
| 93 | MP0006072_abnormal_retinal_apoptosis | 0.71416719 |
| 94 | MP0005551_abnormal_eye_electrophysiolog | 0.67134149 |
| 95 | MP0002971_abnormal_brown_adipose | 0.66199681 |
| 96 | MP0005646_abnormal_pituitary_gland | 0.66166935 |
| 97 | MP0003123_paternal_imprinting | 0.64497618 |
| 98 | MP0001502_abnormal_circadian_rhythm | 0.62183188 |
| 99 | MP0003121_genomic_imprinting | 0.61836362 |
| 100 | MP0001299_abnormal_eye_distance/ | 0.61759658 |
| 101 | MP0005375_adipose_tissue_phenotype | 0.60499611 |
| 102 | MP0003879_abnormal_hair_cell | 0.60390864 |
| 103 | MP0004147_increased_porphyrin_level | 0.59711179 |
| 104 | * MP0000266_abnormal_heart_morphology | 0.58349539 |
| 105 | MP0003567_abnormal_fetal_cardiomyocyte | 0.58158686 |
| 106 | MP0001485_abnormal_pinna_reflex | 0.58122381 |
| 107 | MP0005666_abnormal_adipose_tissue | 0.57551956 |
| 108 | MP0002229_neurodegeneration | 0.56577706 |
| 109 | MP0002152_abnormal_brain_morphology | 0.56272921 |
| 110 | MP0002752_abnormal_somatic_nervous | 0.56038550 |
| 111 | MP0005165_increased_susceptibility_to | 0.54842753 |
| 112 | MP0002078_abnormal_glucose_homeostasis | 0.48826706 |
| 113 | MP0005535_abnormal_body_temperature | 0.45668816 |
| 114 | MP0000372_irregular_coat_pigmentation | 0.40604407 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Sudden death (HP:0001699) | 5.86199862 |
| 2 | Calf muscle hypertrophy (HP:0008981) | 5.15387881 |
| 3 | Acute necrotizing encephalopathy (HP:0006965) | 5.01744847 |
| 4 | Muscle hypertrophy of the lower extremities (HP:0008968) | 4.97515315 |
| 5 | Exercise-induced myalgia (HP:0003738) | 4.95495474 |
| 6 | Abnormal mitochondria in muscle tissue (HP:0008316) | 4.80081696 |
| 7 | Exercise-induced muscle cramps (HP:0003710) | 4.78644571 |
| 8 | Abnormality of the calf musculature (HP:0001430) | 4.40885932 |
| 9 | Atrial fibrillation (HP:0005110) | 4.39865710 |
| 10 | Progressive macrocephaly (HP:0004481) | 4.31146500 |
| 11 | Primary atrial arrhythmia (HP:0001692) | 4.20030212 |
| 12 | Ventricular tachycardia (HP:0004756) | 4.11897450 |
| 13 | Supraventricular tachycardia (HP:0004755) | 4.06404940 |
| 14 | Myopathic facies (HP:0002058) | 4.02793969 |
| 15 | Distal arthrogryposis (HP:0005684) | 3.98327745 |
| 16 | Supraventricular arrhythmia (HP:0005115) | 3.97566073 |
| 17 | Mitochondrial inheritance (HP:0001427) | 3.96999929 |
| 18 | Pheochromocytoma (HP:0002666) | 3.96074352 |
| 19 | Acute encephalopathy (HP:0006846) | 3.92907879 |
| 20 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 3.92172436 |
| 21 | Distal lower limb muscle weakness (HP:0009053) | 3.84667309 |
| 22 | Muscle fiber splitting (HP:0003555) | 3.67296639 |
| 23 | Neuroendocrine neoplasm (HP:0100634) | 3.63402217 |
| 24 | Syncope (HP:0001279) | 3.61940598 |
| 25 | Prolonged QT interval (HP:0001657) | 3.59607442 |
| 26 | Increased CSF lactate (HP:0002490) | 3.55536038 |
| 27 | EMG: neuropathic changes (HP:0003445) | 3.49110496 |
| 28 | Focal motor seizures (HP:0011153) | 3.48049846 |
| 29 | Hepatocellular necrosis (HP:0001404) | 3.47289420 |
| 30 | Lipoatrophy (HP:0100578) | 3.47046903 |
| 31 | Palpitations (HP:0001962) | 3.43527898 |
| 32 | Myoglobinuria (HP:0002913) | 3.33779383 |
| 33 | Myotonia (HP:0002486) | 3.31195752 |
| 34 | Hyporeflexia of lower limbs (HP:0002600) | 3.28657845 |
| 35 | Abnormality of the left ventricular outflow tract (HP:0011103) | 3.24968681 |
| 36 | Subaortic stenosis (HP:0001682) | 3.24968681 |
| 37 | Round ear (HP:0100830) | 3.24965453 |
| 38 | Hepatic necrosis (HP:0002605) | 3.16599723 |
| 39 | Areflexia of lower limbs (HP:0002522) | 3.14006546 |
| 40 | Abnormality of glycolysis (HP:0004366) | 3.11864766 |
| 41 | Increased serum pyruvate (HP:0003542) | 3.11864766 |
| 42 | Bundle branch block (HP:0011710) | 3.04249822 |
| 43 | Frequent falls (HP:0002359) | 3.00377244 |
| 44 | Ventricular fibrillation (HP:0001663) | 2.95085819 |
| 45 | Ventricular arrhythmia (HP:0004308) | 2.93598546 |
| 46 | * EMG: myopathic abnormalities (HP:0003458) | 2.91881032 |
| 47 | Left ventricular hypertrophy (HP:0001712) | 2.87355718 |
| 48 | Myokymia (HP:0002411) | 2.83462501 |
| 49 | Dilated cardiomyopathy (HP:0001644) | 2.77086995 |
| 50 | Abnormal EKG (HP:0003115) | 2.76114075 |
| 51 | Ulnar deviation of the wrist (HP:0003049) | 2.71673023 |
| 52 | * Exercise intolerance (HP:0003546) | 2.69967459 |
| 53 | Cerebral edema (HP:0002181) | 2.68658654 |
| 54 | Distal lower limb amyotrophy (HP:0008944) | 2.68065490 |
| 55 | Calcaneovalgus deformity (HP:0001848) | 2.67507850 |
| 56 | Atonic seizures (HP:0010819) | 2.67302940 |
| 57 | Respiratory failure (HP:0002878) | 2.66653885 |
| 58 | Mildly elevated creatine phosphokinase (HP:0008180) | 2.59550767 |
| 59 | Optic disc pallor (HP:0000543) | 2.56251445 |
| 60 | Right ventricular cardiomyopathy (HP:0011663) | 2.53805366 |
| 61 | Asymmetric septal hypertrophy (HP:0001670) | 2.49634666 |
| 62 | Conjunctival hamartoma (HP:0100780) | 2.45079106 |
| 63 | Deformed tarsal bones (HP:0008119) | 2.44760490 |
| 64 | Absent phalangeal crease (HP:0006109) | 2.43906940 |
| 65 | Limb-girdle muscle atrophy (HP:0003797) | 2.41281148 |
| 66 | * Lactic acidosis (HP:0003128) | 2.40963881 |
| 67 | Rhabdomyolysis (HP:0003201) | 2.38325900 |
| 68 | Visual hallucinations (HP:0002367) | 2.36596146 |
| 69 | Lower limb amyotrophy (HP:0007210) | 2.34984989 |
| 70 | Focal seizures (HP:0007359) | 2.34309223 |
| 71 | Muscle stiffness (HP:0003552) | 2.33685573 |
| 72 | Neoplasm of the peripheral nervous system (HP:0100007) | 2.30313582 |
| 73 | Rimmed vacuoles (HP:0003805) | 2.30264090 |
| 74 | Epileptic encephalopathy (HP:0200134) | 2.28490469 |
| 75 | Difficulty running (HP:0009046) | 2.27414519 |
| 76 | Muscle fiber inclusion bodies (HP:0100299) | 2.27075648 |
| 77 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 2.26684505 |
| 78 | Scapular winging (HP:0003691) | 2.26375958 |
| 79 | Heart block (HP:0012722) | 2.26242794 |
| 80 | Leukodystrophy (HP:0002415) | 2.25579156 |
| 81 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 2.22927604 |
| 82 | Abnormality of alanine metabolism (HP:0010916) | 2.22927604 |
| 83 | Hyperalaninemia (HP:0003348) | 2.22927604 |
| 84 | Type 1 muscle fiber predominance (HP:0003803) | 2.19632395 |
| 85 | Increased intramyocellular lipid droplets (HP:0012240) | 2.18749447 |
| 86 | Fetal akinesia sequence (HP:0001989) | 2.17808728 |
| 87 | Increased variability in muscle fiber diameter (HP:0003557) | 2.15087520 |
| 88 | Increased connective tissue (HP:0009025) | 2.14861820 |
| 89 | Progressive muscle weakness (HP:0003323) | 2.13598437 |
| 90 | * Generalized muscle weakness (HP:0003324) | 2.12721910 |
| 91 | Abnormal atrioventricular conduction (HP:0005150) | 2.12479765 |
| 92 | Proximal amyotrophy (HP:0007126) | 2.11149076 |
| 93 | Increased hepatocellular lipid droplets (HP:0006565) | 2.11137014 |
| 94 | Absence seizures (HP:0002121) | 2.09822022 |
| 95 | Neoplasm of the adrenal gland (HP:0100631) | 2.09503118 |
| 96 | Gowers sign (HP:0003391) | 2.07694903 |
| 97 | Neck muscle weakness (HP:0000467) | 2.06713080 |
| 98 | Bulbar palsy (HP:0001283) | 2.03170658 |
| 99 | Increased muscle lipid content (HP:0009058) | 2.02900583 |
| 100 | Febrile seizures (HP:0002373) | 2.02331190 |
| 101 | Abnormality of the foot musculature (HP:0001436) | 2.01657262 |
| 102 | Lipid accumulation in hepatocytes (HP:0006561) | 2.01405206 |
| 103 | Abnormal finger flexion creases (HP:0006143) | 2.01286338 |
| 104 | Athetosis (HP:0002305) | 2.00298607 |
| 105 | Abnormality of the shoulder girdle musculature (HP:0001435) | 1.99065657 |
| 106 | Double outlet right ventricle (HP:0001719) | 1.98591130 |
| 107 | Congenital malformation of the right heart (HP:0011723) | 1.98591130 |
| 108 | X-linked dominant inheritance (HP:0001423) | 1.98046246 |
| 109 | Difficulty climbing stairs (HP:0003551) | 1.96603337 |
| 110 | Hypoplastic left heart (HP:0004383) | 1.96312873 |
| 111 | Muscular dystrophy (HP:0003560) | 1.95629428 |
| 112 | Foot dorsiflexor weakness (HP:0009027) | 1.95358043 |
| 113 | Nemaline bodies (HP:0003798) | 1.94670081 |
| 114 | Anxiety (HP:0000739) | 1.92437591 |
| 115 | Abnormality of the vocal cords (HP:0008777) | 1.92380198 |
| 116 | Central scotoma (HP:0000603) | 1.91427041 |
| 117 | Increased serum lactate (HP:0002151) | 1.89299286 |
| 118 | Progressive inability to walk (HP:0002505) | 1.89291720 |
| 119 | Abnormality of skeletal muscle fiber size (HP:0012084) | 1.88669751 |
| 120 | Generalized tonic-clonic seizures (HP:0002069) | 1.88382199 |
| 121 | Malignant hyperthermia (HP:0002047) | 1.87785829 |
| 122 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 1.86991723 |
| 123 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 1.86991723 |
| 124 | Dialeptic seizures (HP:0011146) | 1.86853494 |
| 125 | Respiratory insufficiency due to muscle weakness (HP:0002747) | 1.86812328 |
| 126 | Weak cry (HP:0001612) | 1.86715380 |
| 127 | Hamartoma of the eye (HP:0010568) | 1.86423433 |
| 128 | Atrioventricular block (HP:0001678) | 1.85399396 |
| 129 | Hyperventilation (HP:0002883) | 1.84963815 |
| 130 | Steppage gait (HP:0003376) | 1.81461213 |
| 131 | Waddling gait (HP:0002515) | 1.76847769 |
| 132 | Abnormality of the hip-girdle musculature (HP:0001445) | 1.67664624 |
| 133 | Abnormality of the musculature of the pelvis (HP:0001469) | 1.67664624 |
| 134 | Hyperkalemia (HP:0002153) | 1.65073923 |
| 135 | Limb-girdle muscle weakness (HP:0003325) | 1.64374788 |
| 136 | Hip contracture (HP:0003273) | 1.64265057 |
| 137 | Shoulder girdle muscle weakness (HP:0003547) | 1.62564033 |
| 138 | Oligomenorrhea (HP:0000876) | 1.56757478 |
| 139 | Fatigable weakness (HP:0003473) | 1.53974187 |
| 140 | Abnormality of the neuromuscular junction (HP:0003398) | 1.53974187 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | OBSCN | 3.74294467 |
| 2 | MYLK | 3.29751798 |
| 3 | PHKG2 | 3.22149228 |
| 4 | PHKG1 | 3.22149228 |
| 5 | TTN | 2.98029753 |
| 6 | PDK3 | 2.58336601 |
| 7 | PDK4 | 2.58336601 |
| 8 | LMTK2 | 2.36985025 |
| 9 | NTRK3 | 2.34251586 |
| 10 | MAP3K4 | 2.33791862 |
| 11 | CASK | 2.29860575 |
| 12 | MAP3K12 | 2.07976732 |
| 13 | NME1 | 1.92675209 |
| 14 | MARK1 | 1.92347431 |
| 15 | MAP2K7 | 1.91775982 |
| 16 | MINK1 | 1.89854744 |
| 17 | EPHA4 | 1.86998310 |
| 18 | NEK1 | 1.84702291 |
| 19 | MUSK | 1.80603903 |
| 20 | MAP3K9 | 1.78193532 |
| 21 | PLK2 | 1.72453799 |
| 22 | PIK3CA | 1.65530737 |
| 23 | LIMK1 | 1.57158370 |
| 24 | ARAF | 1.56346110 |
| 25 | STK24 | 1.55605261 |
| 26 | PAK3 | 1.54807660 |
| 27 | DMPK | 1.49276295 |
| 28 | MAP2K4 | 1.48637314 |
| 29 | PINK1 | 1.45944044 |
| 30 | PDK2 | 1.44404665 |
| 31 | GRK7 | 1.40442001 |
| 32 | PIK3CG | 1.38930690 |
| 33 | CAMK2D | 1.38213541 |
| 34 | WNK4 | 1.33794516 |
| 35 | PNCK | 1.32509571 |
| 36 | GRK5 | 1.29858923 |
| 37 | CAMK2A | 1.26889507 |
| 38 | PAK6 | 1.17575542 |
| 39 | PTK2B | 1.13617072 |
| 40 | STK39 | 1.10478585 |
| 41 | KSR2 | 1.06708389 |
| 42 | LATS2 | 1.04471747 |
| 43 | MAP3K7 | 1.04011117 |
| 44 | MAPK13 | 1.03394213 |
| 45 | DAPK3 | 1.01431034 |
| 46 | PRPF4B | 0.99410304 |
| 47 | KSR1 | 0.98549712 |
| 48 | MAPKAPK3 | 0.95933293 |
| 49 | UHMK1 | 0.95540275 |
| 50 | ROCK2 | 0.95236061 |
| 51 | ILK | 0.93838048 |
| 52 | CDC42BPA | 0.92877423 |
| 53 | PRKAA1 | 0.91683723 |
| 54 | NTRK1 | 0.91060041 |
| 55 | ROCK1 | 0.90214243 |
| 56 | ERBB3 | 0.86570212 |
| 57 | PRKCE | 0.85955963 |
| 58 | CAMK2B | 0.82998869 |
| 59 | NTRK2 | 0.80566051 |
| 60 | MAPK12 | 0.80247925 |
| 61 | CDK5 | 0.80144138 |
| 62 | STK38L | 0.77098840 |
| 63 | PRKCG | 0.76387733 |
| 64 | PKN2 | 0.75481676 |
| 65 | CAMK2G | 0.75109991 |
| 66 | WNK1 | 0.74215213 |
| 67 | BCR | 0.73684342 |
| 68 | DAPK2 | 0.72505234 |
| 69 | AKT2 | 0.72484653 |
| 70 | CDK14 | 0.67836545 |
| 71 | FER | 0.67537025 |
| 72 | PKN1 | 0.66819056 |
| 73 | PRKAA2 | 0.66062955 |
| 74 | CAMK1 | 0.65252149 |
| 75 | CDK19 | 0.64967425 |
| 76 | TRPM7 | 0.64911011 |
| 77 | PRKD3 | 0.64610019 |
| 78 | ADRBK1 | 0.62850490 |
| 79 | OXSR1 | 0.61634889 |
| 80 | CDK18 | 0.59073308 |
| 81 | STK38 | 0.57707195 |
| 82 | SGK223 | 0.56573382 |
| 83 | SGK494 | 0.56573382 |
| 84 | DYRK1B | 0.56227045 |
| 85 | PRKD1 | 0.56052276 |
| 86 | PRKACA | 0.55519345 |
| 87 | DAPK1 | 0.55050488 |
| 88 | CDK15 | 0.54653695 |
| 89 | CAMKK2 | 0.53121229 |
| 90 | MAPK4 | 0.48485223 |
| 91 | MAP3K5 | 0.48443359 |
| 92 | PRKACB | 0.48005301 |
| 93 | TESK1 | 0.47850701 |
| 94 | BRAF | 0.46402337 |
| 95 | EPHA3 | 0.46329764 |
| 96 | MAP2K6 | 0.46045484 |
| 97 | RPS6KA3 | 0.45315913 |
| 98 | MAP3K6 | 0.44833416 |
| 99 | TIE1 | 0.44799047 |
| 100 | CDK11A | 0.44094422 |
| 101 | MAP2K1 | 0.43171088 |
| 102 | CAMK4 | 0.42749148 |
| 103 | STK16 | 0.41387527 |
| 104 | TNIK | 0.40088471 |
| 105 | BCKDK | 0.38413668 |
| 106 | RET | 0.38258530 |
| 107 | AKT3 | 0.38000743 |
| 108 | SGK3 | 0.37501693 |
| 109 | RAF1 | 0.37303372 |
| 110 | NEK9 | 0.37088947 |
| 111 | SGK1 | 0.37088042 |
| 112 | MAPK10 | 0.35866050 |
| 113 | PRKACG | 0.35611764 |
| 114 | CCNB1 | 0.35316667 |
| 115 | TSSK6 | 0.35314191 |
| 116 | MAP2K3 | 0.35035992 |
| 117 | CSNK1G2 | 0.34863151 |
| 118 | WNK3 | 0.34841204 |
| 119 | RIPK1 | 0.33952030 |
| 120 | SGK2 | 0.33431128 |
| 121 | PRKG1 | 0.32344515 |
| 122 | CAMKK1 | 0.32079814 |
| 123 | MAPK7 | 0.31979023 |
| 124 | DYRK1A | 0.31712384 |
| 125 | ZAK | 0.30995345 |
| 126 | MOS | 0.29624396 |
| 127 | STK11 | 0.28548069 |
| 128 | MAP4K2 | 0.24348397 |
| 129 | CSNK1G3 | 0.22937478 |
| 130 | STK4 | 0.22385085 |
| 131 | DYRK2 | 0.22106232 |
| 132 | CSNK1G1 | 0.21142659 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 4.49399255 |
| 2 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 4.21371506 |
| 3 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 4.04982314 |
| 4 | Parkinsons disease_Homo sapiens_hsa05012 | 4.04611279 |
| 5 | Alzheimers disease_Homo sapiens_hsa05010 | 3.23484036 |
| 6 | Huntingtons disease_Homo sapiens_hsa05016 | 2.71414360 |
| 7 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 2.52885763 |
| 8 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 2.35090550 |
| 9 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 2.25830898 |
| 10 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 2.24253561 |
| 11 | Nicotine addiction_Homo sapiens_hsa05033 | 2.23915847 |
| 12 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 2.09395125 |
| 13 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.93667748 |
| 14 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.73705553 |
| 15 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 1.73339407 |
| 16 | Circadian entrainment_Homo sapiens_hsa04713 | 1.67839360 |
| 17 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 1.67494917 |
| 18 | GABAergic synapse_Homo sapiens_hsa04727 | 1.62831061 |
| 19 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 1.61189036 |
| 20 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.59716389 |
| 21 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.50698091 |
| 22 | Long-term potentiation_Homo sapiens_hsa04720 | 1.50006647 |
| 23 | Morphine addiction_Homo sapiens_hsa05032 | 1.45180393 |
| 24 | Olfactory transduction_Homo sapiens_hsa04740 | 1.44827218 |
| 25 | Amphetamine addiction_Homo sapiens_hsa05031 | 1.36600865 |
| 26 | Dopaminergic synapse_Homo sapiens_hsa04728 | 1.35436746 |
| 27 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.32968962 |
| 28 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.31584798 |
| 29 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.30495753 |
| 30 | Glutamatergic synapse_Homo sapiens_hsa04724 | 1.29524391 |
| 31 | Carbon metabolism_Homo sapiens_hsa01200 | 1.27916047 |
| 32 | * Calcium signaling pathway_Homo sapiens_hsa04020 | 1.26538107 |
| 33 | Taste transduction_Homo sapiens_hsa04742 | 1.26492306 |
| 34 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.25629181 |
| 35 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.24841232 |
| 36 | Insulin secretion_Homo sapiens_hsa04911 | 1.24821065 |
| 37 | Renin secretion_Homo sapiens_hsa04924 | 1.23799139 |
| 38 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.22024633 |
| 39 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 1.18748305 |
| 40 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 1.18434930 |
| 41 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.15635260 |
| 42 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.15264207 |
| 43 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.15086979 |
| 44 | Salivary secretion_Homo sapiens_hsa04970 | 1.13047220 |
| 45 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.12030949 |
| 46 | * cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 1.04652598 |
| 47 | Long-term depression_Homo sapiens_hsa04730 | 0.98932772 |
| 48 | Gap junction_Homo sapiens_hsa04540 | 0.95116400 |
| 49 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.89669325 |
| 50 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.88408297 |
| 51 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.85550244 |
| 52 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.83848555 |
| 53 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.82585204 |
| 54 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.81926183 |
| 55 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.79286234 |
| 56 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.78890512 |
| 57 | Cocaine addiction_Homo sapiens_hsa05030 | 0.78662152 |
| 58 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.77556180 |
| 59 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.74174177 |
| 60 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.65965583 |
| 61 | Axon guidance_Homo sapiens_hsa04360 | 0.64707057 |
| 62 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.64017536 |
| 63 | Insulin resistance_Homo sapiens_hsa04931 | 0.63736305 |
| 64 | Melanogenesis_Homo sapiens_hsa04916 | 0.63411204 |
| 65 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.63063244 |
| 66 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.61931711 |
| 67 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.58613273 |
| 68 | Phototransduction_Homo sapiens_hsa04744 | 0.58465139 |
| 69 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.57056778 |
| 70 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.55640050 |
| 71 | Proteasome_Homo sapiens_hsa03050 | 0.54943690 |
| 72 | Viral myocarditis_Homo sapiens_hsa05416 | 0.53939446 |
| 73 | Sulfur relay system_Homo sapiens_hsa04122 | 0.53233717 |
| 74 | Tight junction_Homo sapiens_hsa04530 | 0.53202323 |
| 75 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.52425613 |
| 76 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.52342691 |
| 77 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.51841314 |
| 78 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.51740010 |
| 79 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.51619621 |
| 80 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.48976356 |
| 81 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.48909084 |
| 82 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.47968861 |
| 83 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.45456702 |
| 84 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.43935144 |
| 85 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.43723545 |
| 86 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.42944943 |
| 87 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.42630245 |
| 88 | Bile secretion_Homo sapiens_hsa04976 | 0.41009720 |
| 89 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.40852500 |
| 90 | Peroxisome_Homo sapiens_hsa04146 | 0.40301774 |
| 91 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.40007171 |
| 92 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.39922099 |
| 93 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.39666627 |
| 94 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.37920860 |
| 95 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.37221492 |
| 96 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.36647711 |
| 97 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.35778211 |
| 98 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.35636674 |
| 99 | Glioma_Homo sapiens_hsa05214 | 0.34621291 |
| 100 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.34309864 |
| 101 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.34236036 |
| 102 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.33680358 |
| 103 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.32940595 |
| 104 | Circadian rhythm_Homo sapiens_hsa04710 | 0.32844485 |
| 105 | Focal adhesion_Homo sapiens_hsa04510 | 0.32771962 |
| 106 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.32184172 |
| 107 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.31899884 |
| 108 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.31374681 |
| 109 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.30953557 |
| 110 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.29187739 |
| 111 | Galactose metabolism_Homo sapiens_hsa00052 | 0.29066149 |
| 112 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.28027179 |
| 113 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.26787314 |
| 114 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.26780787 |
| 115 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.26112486 |
| 116 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.25541810 |
| 117 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.24362201 |
| 118 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.23834671 |
| 119 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.23764230 |
| 120 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.22519165 |
| 121 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.21977212 |
| 122 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.21568600 |
| 123 | Melanoma_Homo sapiens_hsa05218 | 0.21299941 |
| 124 | Phagosome_Homo sapiens_hsa04145 | 0.20242444 |
| 125 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.19981547 |
| 126 | Metabolic pathways_Homo sapiens_hsa01100 | 0.18436286 |

